RayKnowChina Research Map
Shortlist

Not yet recruitingCoronary heart diseasePhase not stated

Registered title, quoted from ClinicalTrials.gov

AI-Based CT Analysis of Coronary Plaque Evolution

An open trial on coronary heart disease, registered on ClinicalTrials.gov. Led by Zhejiang Hospital; 3 other hospitals on this site are listed as study sites.

Status, phase and start date as registered on ClinicalTrials.gov on 18 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.

The study team’s contact details are on the registry record. This site does not pass on enquiries.

Hospitals in mainland China listed for this trial 4

Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.

  1. Lead sponsorZhejiang Hospital浙江医院HangzhouHospital page
  2. Study siteAffiliated Hospital of Hangzhou Normal University杭州师范大学附属医院HangzhouHospital page
  3. Study siteFirst Affiliated Hospital, Zhejiang University浙江大学医学院附属第一医院HangzhouHospital page
  4. Study siteSir Run Run Shaw Hospital浙江大学医学院附属邵逸夫医院HangzhouHospital page

The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov

Source: ClinicalTrials.gov record NCT07886996, read on 18 Nov 2026; hospital names matched to this site’s hospital list. How names are matched

Checklist for this trial 2

Only the points this trial’s record answers definitely: the registered age and sex, and criteria lines that state a number, score, stage or named test, quoted word for word. Tick a point once it has been compared with the medical records.

Show the checklist (2 points)Hide the checklist
  1. 18 years to Not stated; sex: all

    Registered eligibility fields

  2. Pregnancy.

    Exclusion criterion 2

Ticks stay on this page; they are not saved or sent. Meeting every point is not enough: the study team decides after its own screening. Lines that need the team’s judgement, such as “sufficient organ function”, are not in this list; they are in the full criteria below. Not stated definitely in this record: diagnosis and how it was confirmed; stage or severity, as the trial defines it; earlier treatment; day-to-day activity level; blood tests: counts, liver and kidney function; scans and measurable lesions; other conditions the trial excludes.

Questions to ask the study team

Picked from the record by fixed keyword rules (not by AI, not checked by hand) and quoted from ClinicalTrials.gov, NCT07886996, read on 10 Nov 2026.

Registered criteria

Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.

Inclusion Criteria:

  • Adults aged 18 years or older.
  • Baseline CCTA demonstrates coronary plaque in the LAD, LCX, RCA, or a major branch with reference diameter >=2.0 mm.
  • No prior percutaneous coronary intervention or coronary artery bypass grafting.
  • Baseline CCTA and at least one follow-up CCTA are available, with an interval of at least 6 months, preferably 12-36 months.
  • Target segments can be longitudinally matched and non-calcified plaque volume and total vessel volume can be quantified.
  • Image quality meets the core laboratory requirements.

Exclusion Criteria:

  • Severe comorbid disease, active malignancy, acute or chronic inflammation, connective tissue or autoimmune disease, or life expectancy less than 1 year.
  • Pregnancy.
  • Prior PCI stent implantation or CABG.
  • In-stent lesions, complete occlusion, thrombus, left main or ostial lesions, or other lesions preventing the planned hemodynamic or biomechanical analyses.
  • Image quality or key data judged inadequate by the core laboratory.

Quoted from ClinicalTrials.gov, NCT07886996, participation criteria. Read on 10 Nov 2026.

Where this information comes from

The registry record

ClinicalTrials.gov (US National Library of Medicine), record NCT07886996, read on 18 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.

Diseases and hospitals

The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions

What is left out

Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.

Suggest a correctionClinicalTrials.gov NCT07886996